Submitted by Anonymous (not verified) on 24 May 2024 - 16:00
Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos), daunorubicin,cytarabine, Date of authorisation: 23/08/2018, Revision: 10, Status: Authorised
Source: